Product
Fluocinolone Acetonide Intravitreal Implant
1 clinical trial
2 indications
Indication
UveitisIndication
posteriorClinical trial
Phase 4 Study of YUTIQ® (Fluocinolone Acetonide Intravitreal Implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation Study)Status: Recruiting, Estimated PCD: 2025-11-01